Consun Pharmaceutical Group Limited (HKG:1681)
15.99
-0.12 (-0.74%)
Apr 29, 2026, 4:08 PM HKT
HKG:1681 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 910.46 | 784.53 | 682.91 | 590.17 | Upgrade
|
| Depreciation & Amortization | - | 63.99 | 78.09 | 76.36 | 72.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.35 | 0.85 | 4.12 | 1.99 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.09 | -0.23 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | 0.07 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | -1.78 | 23.41 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -8.78 | -12.6 | -32.49 | -18.04 | Upgrade
|
| Other Operating Activities | - | -33.07 | -14.33 | 39.93 | -90.34 | Upgrade
|
| Change in Accounts Receivable | - | -27.9 | -1.71 | 113.87 | 114.21 | Upgrade
|
| Change in Inventory | - | 77.41 | -89.69 | -54.9 | -39.56 | Upgrade
|
| Change in Accounts Payable | - | 116.92 | 80.76 | 114.41 | 50.99 | Upgrade
|
| Change in Unearned Revenue | - | -4.55 | -0.46 | 2.26 | 1.67 | Upgrade
|
| Change in Other Net Operating Assets | - | -8.01 | -6.24 | 3 | 18.04 | Upgrade
|
| Operating Cash Flow | - | 1,087 | 818.97 | 947.68 | 725.54 | Upgrade
|
| Operating Cash Flow Growth | - | 32.73% | -13.58% | 30.62% | -16.32% | Upgrade
|
| Capital Expenditures | - | -109 | -52.56 | -51.59 | -98.25 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.33 | 0.15 | 1.2 | 0.32 | Upgrade
|
| Investment in Securities | - | -143.06 | -248.27 | -365.67 | -230 | Upgrade
|
| Other Investing Activities | - | 64.82 | 68.92 | 47.26 | 29.62 | Upgrade
|
| Investing Cash Flow | - | -186.91 | -231.77 | -368.8 | -298.31 | Upgrade
|
| Long-Term Debt Issued | - | 497.55 | 442.39 | 259.32 | 295.72 | Upgrade
|
| Long-Term Debt Repaid | - | -758.2 | -382.93 | -436.67 | -235.81 | Upgrade
|
| Net Debt Issued (Repaid) | - | -260.65 | 59.46 | -177.35 | 59.91 | Upgrade
|
| Issuance of Common Stock | - | 142.99 | 14.2 | 2.64 | 14.57 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -29.07 | -30.15 | Upgrade
|
| Common Dividends Paid | - | -680.54 | -326.25 | -127.49 | -198.08 | Upgrade
|
| Other Financing Activities | - | 68.94 | -27.51 | -10.93 | -12.91 | Upgrade
|
| Financing Cash Flow | - | -729.26 | -280.1 | -342.21 | -166.66 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -11.4 | -9.01 | 17.18 | -4.52 | Upgrade
|
| Net Cash Flow | - | 159.42 | 298.09 | 253.85 | 256.05 | Upgrade
|
| Free Cash Flow | - | 977.99 | 766.41 | 896.09 | 627.29 | Upgrade
|
| Free Cash Flow Growth | - | 27.61% | -14.47% | 42.85% | -23.35% | Upgrade
|
| Free Cash Flow Margin | - | 32.96% | 29.59% | 38.30% | 30.68% | Upgrade
|
| Free Cash Flow Per Share | - | 1.18 | 0.96 | 1.13 | 0.78 | Upgrade
|
| Cash Interest Paid | - | 0.41 | 1.09 | 0.56 | 12.91 | Upgrade
|
| Cash Income Tax Paid | - | 37.18 | 20.03 | 13.21 | 134.68 | Upgrade
|
| Levered Free Cash Flow | - | 681.72 | 507.99 | 650.74 | 464.15 | Upgrade
|
| Unlevered Free Cash Flow | - | 697.28 | 521.28 | 657.57 | 472.21 | Upgrade
|
| Change in Working Capital | - | 153.88 | -17.34 | 178.64 | 145.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.